Drugs / CIK
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT02851784 | Dec 2009 → Jul 2020 | hepatocellular carcinoma | Chinese PLA General Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CIK | “HCC (D ≤5 cm, fewer than three tumors) patients were treated with radical MWA and 4-6 courses of immunotherapy with CIK every year.” NCT02851784 ↗ |
| Route | Other | “DC-CIK and CTL were injected into the abdominal cavity.” NCT02851784 ↗ |